Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Airship AI A | AISP | Oct 16, 2024 | 2.18 | +2.83 |
Akamai Technologies | AKAM | Oct 16, 2024 | 103.58 | +0.28 |
Akanda | AKAN | Oct 16, 2024 | 0.95 | -1.44 |
Akari Therapeutics ADR | AKTX | Oct 16, 2024 | 2.52 | -1.21 |
Akebia Therapeutics | AKBA | Oct 16, 2024 | 1.33 | +1.53 |
Akero Therapeutics | AKRO | Oct 16, 2024 | 31.05 | +3.74 |
Akoustis Technologies | AKTS | Oct 16, 2024 | 0.07 | +10.06 |
Akoya BioSciences | AKYA | Oct 16, 2024 | 3.20 | +2.24 |
Akso Health ADR | AHG | Oct 16, 2024 | 0.99 | -3.26 |
Alamo Group | ALG | Oct 16, 2024 | 181.53 | +0.02 |
Alamos Gold | AGI | Oct 16, 2024 | 19.97 | +1.58 |
Alarm.com | ALRM | Oct 16, 2024 | 53.99 | +0.02 |
Alarum Technologies ADR | ALAR | Oct 16, 2024 | 16.64 | +33.12 |
Alaska Air Group | ALK | Oct 16, 2024 | 46.39 | +2.18 |
Alaunos Therapeutics | TCRT | Oct 16, 2024 | 2.41 | +9.19 |
Albany International | AIN | Oct 16, 2024 | 75.25 | +1.62 |
Albemarle | ALB | Oct 16, 2024 | 98.25 | +2.62 |
Albemarle ADR A Pref | ALB-A | Oct 16, 2024 | 46.49 | +2.38 |
Albertsons Companies A | ACI | Oct 16, 2024 | 18.31 | -0.76 |
Alchemy Investments Acquisition 1 | ALCY | Oct 16, 2024 | 10.90 | -0.06 |
Alchemy Investments Acquisition 1 Units | ALCYU | Oct 16, 2024 | 10.88 | 0.00 |
Alcoa | AA | Oct 16, 2024 | 42.07 | +1.86 |
Alcon | ALC | Oct 16, 2024 | 95.29 | -1.37 |
Aldeyra Therapeutics | ALDX | Oct 16, 2024 | 5.56 | +3.73 |
Alector | ALEC | Oct 16, 2024 | 5.20 | +2.56 |
Alerian Energy Infrastructure E | ENFR | Oct 16, 2024 | 29.55 | +0.75 |
Alerus Financial | ALRS | Oct 16, 2024 | 24.15 | +1.77 |
Alexander & Baldwin | ALEX | Oct 16, 2024 | 18.81 | +0.11 |
Alexanders | ALX | Oct 16, 2024 | 232.97 | -0.36 |
Alexandria Real Estate Equities | ARE | Oct 16, 2024 | 122.67 | +1.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.